High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients

Journal of Thrombosis and Haemostasis

Volumn 18, Issue 7, 2020, Pages 1743-1746

  Llitjos, Jean François ^a   Leclerc, Maxime ^b   Chochois, Camille ^b   Monsallier, Jean Michel ^c   Ramakers, Michel ^b   Auvray, Malika ^b   Merouani, Karim ^c  

^a INSTITUT COCHIN   (France)

^b Mémorial France Etats Unis Hospital   (France)

^c Alençon Mamers Intercommunal Hospital   (France)

Author keywords

anticoagulation; COVID 19; critical care; pulmonary embolism; SARS CoV 2; venous thromboembolism

Indexed keywords

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; CORONAVIRUS DISEASE 2019; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; FRANCE; HUMAN; HYPOXEMIA; INCIDENCE; INTENSIVE CARE; LUNG EMBOLISM; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VENOUS THROMBOEMBOLISM; BETACORONAVIRUS; BLOOD; BLOOD CLOTTING; CLINICAL TRIAL; CORONAVIRUS INFECTION; DRUG EFFECT; HOST PARASITE INTERACTION; MIDDLE AGED; MULTICENTER STUDY; PANDEMIC; PATHOGENICITY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VEIN THROMBOSIS; VIROLOGY; VIRUS PNEUMONIA;

ANTICOAGULANT AGENT;

AGED; ANTICOAGULANTS; BETACORONAVIRUS; BLOOD COAGULATION; CORONAVIRUS INFECTIONS; FEMALE; FRANCE; HOST-PARASITE INTERACTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PANDEMICS; PNEUMONIA, VIRAL; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 85084202569     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.14869     Document Type: Article

References (6)

1. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061.
2. Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020. https://doi.org/10.1001/jama.2020.4683. [Epub ahead of print]
3. Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094–1099.
4. Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023–1026.
5. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;pii: S0049-3848(20)30120-1.
6. Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18:1421–1424.